Advertisement

Topics

Latest "LithoLink Corporation" News Stories - Page: 2

20:49 EST 20th January 2019 | BioPortfolio

Here are the most relevant search results for "LithoLink Corporation" found in our extensive news archives from over 250 global news sources.

More Information about LithoLink Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about LithoLink Corporation for you to read. Along with our medical data and news we also list LithoLink Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of LithoLink Corporation Companies for you to search.

Showing "LithoLink Corporation" News Articles 26–50 of 664

Probably Relevant

International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial

CARLSBAD, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the second patient of the third cohort of the clinical trial for Parkinson's disease was successfu...


Arrayit Corporation Fulfills Clinical Instrumentation Contract with the United States Food and Drug Administration

Sunnyvale, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports fulfillment of a clinical instrumentation contract with the United States Food and Drug Administration (FDA), which involves an exacting series of contractual steps including receiving the solicitation, placing the bid, winning the award, receiving the purcha...

Arrayit Corporation Announces Allergy Testing Services Agreement with a Major Health and Wellness Provider

Sunnyvale, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces a new allergy testing services agreement with a major healthcare company specializing in patient health and wellness. Arrayit offers simple non-invasive testing services that measure reactivity of immunoglobulin E (IgE) antibodies to an extensive panel of f...


Arrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration

Sunnyvale, July 16, 2018 (GLOBE NEWSWIRE) -- July 16, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses the same clinical instrumentation in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the...

Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors

Development collaboration integrates Sartorius Stedim Biotech’s BIOSTAT® STR bioreactors and Repligen’s XCell™ ATF cell retention control technologyCustomers to benefit from simplified, scalable solutions for intensified cell culture GÖTTINGEN, Germany and WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Sartorius Stedim Biotech (SSB) (Euronext: DIM), a leading international supplier...

Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration

Sunnyvale, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports the shipment of clinical instrumentation and quantification software to the United States Food and Drug Administration (FDA).  Arrayit uses the same instrumentation and software to test for allergy and food intolerance as well as pipeline indications for ov...

International Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual Meeting

CARLSBAD, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today it will present at the Society for Neuroscience Annual Meeting (Neuroscience 2018), being held Novembe...

International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018

Increases in Revenues and Profit MarginsNet Income Realized for the Quarter CARLSBAD, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and...

International Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson’s Disease Clinical Trial

CARLSBAD, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today positive 12-month results of the first cohort and six-month interim results of the second cohort of it...

International Stem Cell Corporation Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018

CARLSBAD, Calif., Aug. 15, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced operating results for the three and six months ended June 30, 2018...

Global Display Materia Market Status and Outlook 20182025 [Report Updated: 16082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Vistin Pharma ASA : Head of Energy Trading resigns

Oslo, Norway, 3 January 2019 Torbjørn Kjus, Head of Energy Trading at Vistin Pharma ASA, has decided to resign from his position to pursue other interests. As a result of the resignation of Torbjørn Kjus, the Board of Directors of Vistin Pharma will evaluate the strategic options available for the Energy Trading division going forward. Further information regarding this business unit wi...

Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers

Sunnyvale, Aug. 27, 2018 (GLOBE NEWSWIRE) -- August 27, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces allergy testing partnerships with multiple providers of allergen immunotherapy products including sub-cutaneous, sublingual, and oral allergy medicines designed to treat patients of allergy and asthma.  Allergen immunothe...

Arrayit Corporation Approved for Direct Medicare Billing by the Centers for Medicare and Medicaid Services

Sunnyvale, Sept. 10, 2018 (GLOBE NEWSWIRE) -- September 10, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that Arrayit’s proprietary finger stick allergy microarray test has been approved for direct Medicare billing by the Centers for Medicare and Medicaid Services (CMS).  The Medicare national health insurance program ...

Sam’s Club and Dynavax Technologies Corporation Announce Collaboration to Make HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Available to Sam’s Club Patients

BERKELEY, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX), a leader in developing immunotherapies based on toll-like receptor (TLR) biology, and Sam’s Club, a leading membership warehouse club offering superior products, savings and services to millions of members in nearly 600 clubs, have teamed up to introduce HEPLISAV-B into Sam’s Club retail phar...

Orion Corporation's financial reporting and Annual General Meeting in 2019

ORION CORPORATION          STOCK EXCHANGE RELEASE           18 JULY 2018 at 11.00 EEST                       Orion Corporation's financial reporting and Annual General Meeting in 2019    Orion Corporation will publish its Financial Statement Release 2018 on Wednesday, 6 February 2019. The publication dates of the Interim Reports ...

Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients

 Orion Corporation                                  Press release  4 January 2019 at 9.00 a.m. Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients Orion Corporation, a globally operating Finnish pharmaceutical company, and Fifth Corner Inc., a Finnish startup ...

Fortress Biotech Announces Agreement to Sell Its Majority Stake in National Holdings Corporation to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial

NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that it has entered into an agreement to sell its 56.1 percent majority stake of National Holdings Corporation (NASDAQ: NHLD) (“National”), a lea...

ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018

Amsterdam, The Netherlands - 19 November 2018 Esperite announces that the preparation of its Annual Report 2017 is now under final review by its auditors and should be published before 24 November 2018. About ESPERITEESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.To learn more abou...

Virbac: Availability of the quarterly financial information as of September 30, 2018

Virbac: Availability of the quarterly financial information as of September 30, 2018 Public release - November 14, 2018 The quarterly financial information as of September 30, 2018 is available: ·           on our website: corporate.virbac.com under the section Investors - Financial reports - 2018;·           or on request, under legal and regulatory conditions. ...

ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018

Amsterdam, The Netherlands - 09 November 2018 Esperite announces that the preparation of its Annual Report 2017 is nearly finalized and expects the publication of its Annual Report 2017 before 17 November 2018. About ESPERITEESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.To learn m...

Nicox: Number of voting rights as of October 31.2 018

Nicox SASociété anonyme with a registered capital of € 29,715,320 Head Office:DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On November 5, 2018, MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS (Article L.233-8 II of the Code de Commerce and Artic...

NICOX : Number of voting rights as of December 31.2018

Nicox SASociété anonyme with a registered capital of € 29,715,320 Head Office:DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On January 2, 2019, MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS (Article L.233-8 II of the Code de Commerce and Articl...

NICOX : Number of voting rights as of November 30. 2018

Nicox SASociété anonyme with a registered capital of € 29,715,320 Head Office:DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On December 3, 2018, MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS (Article L.233-8 II of the Code de Commerce and Artic...

Global Instant Adhesive Market Status and Outlook 20182025 [Report Updated: 02082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks